Benzinga's Top Upgrades
July 21, 2015 at 09:28 AM EDT
Goldman Sachs upgraded Anacor Pharmaceuticals Inc (NASDAQ: ANAC) from Neutral to Buy.. The price target for Anacor Pharmaceuticals ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.